Skip to main content

Tarsus Pharmaceuticals, Inc. (TARS)

NASDAQ: TARS · IEX Real-Time Price · USD
25.00 -2.70 (-9.75%)
Nov 26, 2021 1:00 PM EST - Market closed

Total Valuation

TARS has a market cap or net worth of $516.92 million. The enterprise value is $333.12 million.

Market Cap516.92M
Enterprise Value333.12M

Important Dates

The latest earnings date was Wednesday, November 10, 2021 before market open.

Last Earnings DateNov 10, 2021
Ex-Dividend Daten/a

Share Statistics

TARS has 20.68 million shares outstanding. The number of shares has increased by 656.18% in one year.

Shares Outstanding20.68M
Shares Change (YoY)+656.18%
Shares Change (QoQ)+0.42%
Owned by Insiders (%)28.57%
Owned by Institutions (%)62.60%

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ratio9.12
PB Ratio2.89
P/FCF Ratio92.41
PEG Ration/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is n/a, with a EV/FCF ratio of 59.55.

EV / Earningsn/a
EV / Sales5.88
EV / EBITn/a
EV / FCF59.55

Financial Position

Current Ratio18.05
Quick Ratio17.75
Debt / Equityn/a
Debt / EBITDAn/a
Debt / FCFn/a

Financial Efficiency

Return on Equity (ROE)-5.80%
Return on Assets (ROA)-5.50%
Return on Capital (ROIC)-108.30%
Revenue Per Employee$2.83M
Profits Per Employee-$522,150
Employee Count20
Asset Turnover0.30
Inventory Turnovern/a


In the past 12 months, TARS has paid $1,000 in taxes.

Income Tax1,000
Effective Tax Rate-0.01%

Stock Price Statistics

The stock price has increased by +8.70% in the last 52 weeks.

Beta (1Y)n/a
52-Week Price Change+8.70%
50-Day Moving Average27.31
200-Day Moving Average27.17
Average Volume (30 Days)31,674

Short Selling Information

Short Interest323,089
Short % of Shares Out1.56%
Short % of Float5.80%
Short Ratio (days to cover)9.83

Income Statement

In the last 12 months, TARS had revenue of $56.69 million and -$10.44 million in losses. Earnings per share was -$0.53.

Gross Profit54.59M
Operating Income-9.19M
Pretax Income-10.44M
Net Income-10.44M
Earnings Per Share (EPS)-$0.53
Full Income Statement

Balance Sheet

Cash & Cash Equivalents183.80M
Total Debtn/a
Net Cash183.80M
Net Cash Per Share$8.89
Book Value179.14M
Book Value Per Share8.66
Working Capital176.72M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $5.86 million and capital expenditures -$262,000, giving a free cash flow of $5.59 million.

Operating Cash Flow5.86M
Capital Expenditures-262,000
Free Cash Flow5.59M
FCF Per Share$0.27
Full Cash Flow Statement


Gross margin is 96.30%, with operating and profit margins of -16.20% and -18.42%.

Gross Margin96.30%
Operating Margin-16.20%
Pretax Margin-18.42%
Profit Margin-18.42%
EBITDA Margin-17.47%
EBIT Margin-18.43%
FCF Margin9.87%

Dividends & Yields

TARS does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-2.02%
FCF Yield1.08%
Dividend Growth (YoY)n/a
Payout Ration/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Daten/a
Split Typen/a
Split Ration/a